Clinical Trials Browser

INDUSTRY × Pleural Effusion, Malignant × Paclitaxel × Clear all

NCT00343291 2011-06-07

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Phase 2 Completed

121 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant